학술논문
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
Document Type
Article
Author
Loibl, Sibylle; de la Pena, Lorena; Nekljudova, Valentina; Zardavas, Dimitrios; Michiels, Stefan; Denkert, Carsten; Rezai, Mahdi; Bermejo, Begoña; Untch, Michael; Lee, Soo Chin; Turri, Sabine; Urban, Patrick; Kümmel, Sherko; Steger, Guenther; Gombos, Andrea; Lux, Michael; Piccart, Martine J.; Von Minckwitz, Gunter; Baselga, José; Loi, Sherene
Source
In European Journal of Cancer November 2017 85:133-145
Subject
Language
ISSN
0959-8049